Search Results 1521-1530 of 16410 for monoclonal antibody

1. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

   Prior therapy with any of the following: PD-1, PD-L1, CTLA4 antibody, or any other drug targeting T cell checkpoint pathways. ... antibodies or infused ...

2. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

   5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...

3. Immune globulin-dira (intravenous route) - Mayo Clinic

   Description. Immune globulin-dira injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

4. Immune globulin-stwk (intravenous route) - Mayo Clinic

   Description. Immune globulin-stwk injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

5. Smallpox vaccine (injection route) - Mayo Clinic

   It works by causing your immune system to produce its own protection (antibodies) against the virus . This vaccine should only be administered by or under ...

6. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

   [antibody to hepatitis B core antigen] antibody test) are eligible. - Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...

7. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Has been previously treated with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 antibody or any other antibody or drug specifically targeting ...

8. Biopsy recommended for patients with clinical characteristics of IgG4-ROD

   Researchers also collected laboratory values for thyrotropin receptor antibodies, total serum IgG and serum IgG4 . The diagnosis of IgG4-ROD was based on a ...

9. Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies - Mayo Clinic

   Subjects are eligible with or without a documented complement mutation or anti-CFH antibody. Subjects are categorized according to their response to plasma ...

10. Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis - Mayo Clinic

    Documented positive anti-mitochondrial antibody (AMA) titer (>1:40 titer on immunofluorescence or M2 positive by enzyme-linked immunosorbent assay) or PBC ...